Bioregenx (BRGX) Cash from Financing Activities (2022 - 2026)
Bioregenx's (BRGX) quarterly Cash from Financing Activities came in at -$50206.0 in Q1 2026, down 382.05% year-on-year from $17800.1 in Q1 2025, and down 13.73% quarter-over-quarter from -$44143.0 in Q4 2025.
Bioregenx (BRGX) Cash from Financing Activities (2022 - 2026) Analysis & Trends
Bioregenx's Cash from Financing Activities history runs 5 years deep, the most recent figure standing at -$50206.0 for Q1 2026.
- On a quarterly basis, Cash from Financing Activities fell 382.05% year-over-year to -$50206.0 in Q1 2026; TTM through Mar 2026 was -$6693.0, a 104.49% decrease from a year earlier, with the FY2025 full-year figure at $33098.0, down 92.51% from the prior year.
- Cash from Financing Activities declined to -$50206.0 in Q1 2026 per BRGX's latest filing, from -$44143.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $513370.0 in Q4 2023 and bottomed at -$50206.0 in Q1 2026.
- The 5-year median for Cash from Financing Activities is $39118.5 (2022), against an average of $104393.9.
- Across the five-year window, Cash from Financing Activities surged 14571.91% in 2023 and plunged 535.7% in 2025, its largest moves.
- Year by year, Cash from Financing Activities stood at $3499.0 in 2022, then jumped by 14571.91% to $513370.0 in 2023, then plunged by 101.35% to -$6944.0 in 2024, then plunged by 535.7% to -$44143.0 in 2025, then fell by 13.73% to -$50206.0 in 2026.
- Per Business Quant, the three latest BRGX Cash from Financing Activities figures stand at -$50206.0 (Q1 2026), -$44143.0 (Q4 2025), and $70833.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | -262.53 Mn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | -70.02 Mn |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | -137.18 Mn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | -8.42 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | -112.85 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | 512.00 Mn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | 13.46 Mn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | -93.16 Mn |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | -10.67 Mn |
| 10 | Bioregenx | 9.69 Mn | 9.65 Mn | 348,288.00 | -50,206.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50,206.00 |
| Mar 31, 2026 | -50,206.00 |
| Dec 31, 2025 | -44,143.00 |
| Dec 31, 2025 | -44,143.00 |
| Sep 30, 2025 | 70,833.00 |
| Sep 30, 2025 | 70,833.00 |
| Jun 30, 2025 | 16,823.00 |
| Jun 30, 2025 | 16,823.00 |
| Mar 31, 2025 | -10,415.00 |
| Mar 31, 2025 | -10,415.00 |
| Dec 31, 2024 | -6,944.00 |
| Dec 31, 2024 | -6,944.00 |
| Sep 30, 2024 | 46,442.00 |
| Sep 30, 2024 | 46,442.00 |
| Jun 30, 2024 | 120,059.00 |
| Jun 30, 2024 | 120,059.00 |
| Mar 31, 2024 | 282,562.00 |
| Mar 31, 2024 | 282,562.00 |
| Dec 31, 2023 | 513,370.00 |
| Dec 31, 2023 | 513,370.00 |